Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 2:55 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 28 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Arterial Line Clear all

Conditions: Healthy, Hypoxia
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 13 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Hypertension, Cardiac Disease, Surgery
Interventions: Omron Wearable Device, Standard Arterial Line; Other
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: General Anesthesia
Interventions: Arterial line placement; Procedure
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Day to 14 Years
Enrollment: 29 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2018
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Hypertension
Interventions: Advantage MX Module; Device
Lead sponsor: SunTech Medical; Network
Eligibility: 1 Month to 3 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Blood Pressure Measurement
Interventions: Arterial catheterization kit, GE Datex-Ohmeda Finger Clip Pulse Oximeter Sensor, NIBP Cuff (GE Healthcare); Device
Lead sponsor: Sensifree Ltd.; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Pulse Oximetry
Interventions: Not listed
Lead sponsor: University of Minnesota; Other
Eligibility: Up to 17 Years
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Liver and Intrahepatic Bile Duct Carcinoma, Stage III Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8, Stage IIIB Intrahepatic Cholangiocarcinoma AJCC v8, Stage IV Intrahepatic Cholangiocarcinoma AJCC v8, Unresectable Intrahepatic Cholangiocarcinoma
Interventions: Dexamethasone, Floxuridine, Implanted Medical Device, Irinotecan, Leucovorin, Oxaliplatin, Quality-of-Life Assessment; Drug · Device · Other
Lead sponsor: OHSU Knight Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Portland, Oregon

Conditions: Low Oxygen Saturation
Interventions: Not listed
Lead sponsor: Children's National Research Institute; Other
Eligibility: Up to 21 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2010
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: Vascular Access Complication
Interventions: Arterial Line Placement; Procedure
Lead sponsor: Temple University; Other
Eligibility: 18 Years to 99 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Radial Artery Cannulation
Interventions: arterial line placement; Procedure
Lead sponsor: University of Iowa; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Blood Pressure
Interventions: Not listed
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2016
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Arterial and Midline Catheterization
Interventions: Computer Assisted Instrument Guidance (CAIG), which supplements existing ultrasound capabilities.; Device
Lead sponsor: Clear Guide Medical; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Camden, New Jersey

Conditions: Blood Pressure Measurement
Interventions: Sensifree's Alpha sensor, Arrow® arterial catheterization kit (Teleflex), GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor; Device
Lead sponsor: Sensifree Ltd.; Industry
Eligibility: 20 Years to 55 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Surgeries Requiring Arterial Lines
Interventions: ultrasound technique, palpation technique; Behavioral · Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 25 Years to 35 Years
Enrollment: 4 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Newark, New Jersey

Conditions: Hypertension, Pulmonary
Interventions: ambrisentan, tadalafil; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 610 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 61
States / cities: Birmingham, Alabama • Mobile, Alabama • Phoenix, Arizona + 50 more

Conditions: Colorectal Adenocarcinoma Metastatic to the Liver
Interventions: Floxuridine (FUDR), Irinotecan (CPT-11), FLUOROURACIL, PANITUMUMAB, DEXAMETHASONE, Leucovorin; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 5
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Commack, New York + 2 more

Conditions: Blood Pressure Measurement
Interventions: GE Datex-Ohmeda Oxy-F Finger Clip Pulse Oximeter Sensor, Arrow® arterial catheterization kit (Teleflex); Device
Lead sponsor: Sensifree Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 6 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Louisville, Colorado

Conditions: Renal Failure, Hemodynamics
Interventions: Not listed
Lead sponsor: Baystate Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Springfield, Massachusetts

Conditions: Arterial Catheters, Catheter Related Complication
Interventions: Silk 0-0 suture covered by chlorhexidine gluconate dressing, 2-octyl cyanoacrylate covered by chlorhexidine gluconate dressing; Procedure
Lead sponsor: CHRISTUS Health; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Corpus Christi, Texas

Conditions: Unstable Blood Pressure, Hypotension
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 24 Weeks to 44 Weeks
Enrollment: 80 participants
Timeline: 2025 – 2026
U.S. locations: 2
States / cities: Boston, Massachusetts

Conditions: Blood Pressure, Arterial Line, Anesthesia
Interventions: Not listed
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years to 100 Years
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Cholangiocarcinoma
Interventions: TheraSphere® Yttrium-90 (Y-90) Microspheres; Device
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2015
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Adult Patient Undergoing Major Surgery
Interventions: Masimo hemoglobin-meter, drawing blood sample; Device · Biological
Lead sponsor: University of California, Irvine; Other
Eligibility: 18 Years and older
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Orange, California

Conditions: Subjects With an Existing Intra-arterial Line
Interventions: Not listed
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 1 Month to 18 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013
U.S. locations: 2
States / cities: Los Angeles, California • Orem, Utah

Search by objective public record fields.

Controlled Acute Hypoxia Study - Abbreviated Sensor Line

A Pilot Study to Assess the Accuracy of Blood Pressure Assessment by the Omron HeartGuide Smartwatch

Ultrasound Guided Arterial Line Placement in Long Axis Versus Short Axis in Pediatric Patients

Clinical Validation of Suntech Advantage MX With Suntech Neonate and Children Cuff Line

Data Collection of Arterial Line Waveform and BP Values

Pulse Oximetry and Skin Pigmentation - Peds

mFOLFIRINOX Followed by Hepatic Arterial Infusion of Floxuridine and Dexamethasone With Systemic mFOLFIRI for Unresectable Liver-dominant Intrahepatic Cholangiocarcinoma

Clinical Performance Evaluation of Pediatric and Neonatal Low Saturation Oximetry Sensors

Ultrasound Guided Versus Landmark Guided Arterial Line Placement by Emergency Medicine Interns

Target Sign vs Palpation for Radial Arterial Line Placement

Non-invasive Blood Pressure (BP) Monitoring Compared to A-Line BP Monitoring

Computer Assisted Instrument Guidance (CAIG) For Arterial Line Placement

Evaluation of Sensifree's Alpha Sensor Signal Morphology Compared to Arterial Line and PPG Signal Morphologies

Comparing Palpation Guided and Ultrasound Guided Arterial Line Placement

A Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects With Pulmonary Arterial Hypertension (PAH)

Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver

Continuous Non-Invasive Blood Pressure System Data Collection in Comparison to Invasive Radial Arterial Pressure

Hemodynamic Assessment APCO Monitor vs Crit Line for Renal Replacement Rx

Skin Glue Versus Suture for Securing Radial Arterial Lines

Noninvasive Continuous BP Monitoring in Newborns Based on Pulsatile Signal Morphological Features Using NIRS

Non Invasive Continuous Blood Pressure Sensor

Study Of Intrahepatic Arterial Injection of 90-Y Glass Microspheres for Cholangiocarcinoma

Evaluation of the Accuracy and Precision of the Masimo Labs Pulse-Hemoglobin-Meter Monitor in Surgical Patients

Pulse Oximetry_Performance Testing- PCBA-1 (Printed Circuit Board Assembly) NEO/PEDS